Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, today launched four new anti-idiotypic anti...
Bora Pharmaceuticals Co., Ltd. announced that it has successfully entered into an agreement for Emergent BioSolutions’ sterile man...
AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for adults with moderately to severely ac...
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, unveiled a new clinical research laboratory build...
Partnership to accelerate development of lead product candidate, RO-104; a first-in-class tri-specific biologic for treating neovascular age-relat...
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, is embracing the theme of the 60th annual Drug ...
Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on smal...
ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and Célere, a life sciences-focused consultancy i...
Amidst growing concerns from U.S. federal, state and local agencies over Highly Pathogenic Avian Influenza (HPAI) A (H5N1) detections in dairy cows, Inte...
BIO International Convention 2024, The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, and Abu Dhabi...
Asensus Surgical, , a global leader of innovative digital solutions for the operating room, today announced that it has entered into a definitive merger ...
Eisai Co., and Biogen announced that the U.S. Food and Drug Administration (FDA) has accepted Eisai’s Supplemental Biologics License Applicat...
Vetter Advisory Board decides on strategic path forward for further independent and sustainable growth Des Plaines, IL, and Saa...
New CL2 wet lab purpose-built facilities delivered by Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncol...
© 2025 Biopharma Boardroom. All Rights Reserved.
